Literature DB >> 63443

Studies on the altered electrophoretic type of the factor VIII related antigen.

R Ananthakrishnan, S D'Souza, H Ekert.   

Abstract

A distinct sub-group of von Willebrand's disease is characterized by an electrophoretically faster mobility of the factor VIII related antigen. Some of the physico-chemical properties of this variant antigen were investigated in this communication. The effect of temperature was tested by heating aliquots (0.5 ml) for 20 minutes at 45 degrees C, 56 degrees C and 65 degrees C. The variant was found to be denatured at 56 degrees C while the control was denatured at 65 degrees C. The effect of pH was tested by assessing the quantity (Laurell technique) and electrophoretic mobility (two dimensional immunoelectrophoresis) of the antigen in a variety of buffers ranging in pH from 7.0 to 9.5. The quantity of antigen was variable both among variants and controls and the electrophoretic mobility of the variant antigen was faster at all pH's. Molecular weight differences between the variant and controls were not detected since the chromatographic profile of the variant was similar to that of the controls in Sepharose 6 B using a 0.02 M Tris-NaCL buffer at pH 7.0. The affinity of the antigen for human antibody was heterogeneous although the variant exhibited less affinity for one of the human antibodies but not the other. The inhibitory effect was more pronounced in serum than in plasma. Purified IGG, however, did not show any inhibition, as the residual antigen assayed by the Laurell technique, was similar to the expected values. This would imply that non-IgG plasmatic factors could also play a part in the observed inhibition.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 63443     DOI: 10.1007/BF00295620

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  12 in total

1.  Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.

Authors:  S V Dowling; R H Muntz; S D'Souza; H Ekert
Journal:  Thromb Diath Haemorrh       Date:  1975-11-15

2.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

3.  The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs.

Authors:  R Biggs; D E Austen; K W Denson; R Borrett; C R Rizza
Journal:  Br J Haematol       Date:  1972-08       Impact factor: 6.998

4.  The mode of action of antibodies which destroy factor VIII. I. Antibodies which have second-order concentration graphs.

Authors:  R Biggs; D E Austen; K W Denson; C R Rizza; R Borrett
Journal:  Br J Haematol       Date:  1972-08       Impact factor: 6.998

5.  A variant of factor 8 related antigen.

Authors:  P B Kernoff; R Gruson; C R Rizza
Journal:  Br J Haematol       Date:  1974-03       Impact factor: 6.998

6.  Heterogeneity in biological activity of human factor VIII antibodies.

Authors:  J Koutts; D Meyer; K Rickard; L Stott; B G Firkin
Journal:  Br J Haematol       Date:  1975-01       Impact factor: 6.998

7.  Genetic variants of von Willebrand's disease.

Authors:  L Holmberg; I M Nilsson
Journal:  Br Med J       Date:  1972-08-05

8.  Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.

Authors:  J D Olson; W J Brockway; D N Fass; M A Magnuson; E J Bowie
Journal:  Am J Clin Pathol       Date:  1975-02       Impact factor: 2.493

9.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

10.  Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.

Authors:  H J Weiss; L W Hoyer; F R Rickles; A Varma; J Rogers
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.